Aktis Oncology Inc (AKTS)
Aktis Oncology Inc (NASDAQ-AKTS) is a common stock security listed on NASDAQ. The company is in the healthcare sector and biotechnology industry, and the security context is common equity. Aktis Oncology Inc is associated with oncology-focused research activities and the development of cancer-related therapies, with attention on targeted approaches for tumors. As a listed equity, the security reflects ownership in the company rather than a fund, debt instrument, or other structured product. Investors typically use this type of listing to follow the company’s public-market trading and corporate disclosures within the biotechnology space.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-AKTS
|
$19.99
|
-8.7% Downside
|
Fair
|
$35.39
|
61.7% Upside
|
Bargain
|
Fair
|
0.0%
|
December 2, 2026
|
2.5x
|
121.0x
|
1.217 B
|
710.9 M
|
0.9%
|
51.4%
|
10.5
|
115.6%
|
